Key regions: Australia, Italy, France, South Korea, Brazil
The demand for vaccines in Mauritius has been on the rise in recent years, driven by various factors such as increasing awareness about the importance of vaccination, government initiatives to improve healthcare, and the outbreak of diseases.
Customer preferences: Mauritians have shown a growing interest in vaccines and have become more aware of the need to vaccinate themselves and their children. This is due to the increasing availability of information on the internet and social media, which has helped to educate the public on the benefits of vaccines. Additionally, the government has launched several initiatives to encourage vaccination, such as free vaccination programs for children and adults.
Trends in the market: The vaccines market in Mauritius has witnessed a shift towards more advanced vaccines, such as those for HPV and pneumococcal disease, as well as a growing demand for travel vaccines. This trend is likely to continue, as more people become aware of the importance of vaccination and the need to protect themselves against a wider range of diseases. Additionally, the COVID-19 pandemic has highlighted the importance of vaccines and is likely to further boost demand for vaccines in the country.
Local special circumstances: Mauritius is a small island nation with a population of just over 1 million people. The country has a well-developed healthcare system, with both private and public healthcare facilities available. However, the high cost of vaccines can be a barrier for some people, particularly those on lower incomes. The government has attempted to address this issue by providing free vaccines to certain groups, such as children and the elderly.
Underlying macroeconomic factors: Mauritius has a relatively stable economy, with a strong focus on tourism and financial services. The government has invested heavily in healthcare infrastructure and has made efforts to improve the quality of healthcare in the country. Additionally, the country has a high literacy rate, which has helped to increase awareness about the importance of vaccination. The COVID-19 pandemic has had a significant impact on the economy, but the government has continued to prioritize healthcare spending in order to combat the spread of the virus.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
